Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Diagnosis Value of SEMA4C in Breast Cancer

NCT03662633 is registered in ClinicalTrials.gov with Tongji Hospital as lead sponsor.

NCT NCT03662633
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03662633 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Diagnosis Value of SEMA4C in Breast Cancer
Lead sponsor
Tongji Hospital
Phase
Observational
Overall status
Unknown status
Start date
September 1, 2023
Completion date
September 1, 2024
Enrollment
2,300 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

breast neoplasm female